Technical Analysis for ORPH - Open Orphan plc

Grade Last Price % Change Price Change
C 14.0 -1.75% -0.25
ORPH closed unchanged on Monday, May 16, 2022, on 31 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish -1.75%
50 DMA Resistance Bearish -1.75%
Wide Bands Range Expansion -1.75%
20 DMA Resistance Bearish -1.75%
50 DMA Resistance Bearish -1.75%
Shooting Star Candlestick Bearish -1.75%
Lizard Bearish Bearish Day Trade Setup -1.75%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.75%
Doji - Bearish? Reversal -1.75%
Wide Bands Range Expansion -1.75%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
3x Volume Pace about 2 hours ago
2x Volume Pace about 2 hours ago
1.5x Volume Pace about 2 hours ago
10 DMA Support about 3 hours ago
Fell Below Previous Day's Low about 4 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Open Orphan plc operates as a clinical research organization pharmaceutical services company with a focus on virology, vaccine studies, and orphan drugs in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. It operates a virtual rep, a pharmaceutical commercialization platform for rare/orphan disease space; and develops Genomic Health Data platform, a collection of infectious disease progression data. The company also provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. In addition, it offers hVIVO COVID Clear Test, an antibody test for employers in the United Kingdom and Ireland. The company is headquartered in London, the United Kingdom.
Classification

Keywords: Health Biotechnology Life Sciences Clinical Trial Pharmaceutical Industry Drug Discovery Health Sciences Clinical Research Infectious Disease Vaccine Design Of Experiments Pharmaceuticals Policy Food And Drug Administration Clinical Trial Services

Is ORPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.0
52 Week Low 10.55
Average Volume 1,798,648
200-Day Moving Average 19.36
50-Day Moving Average 14.73
20-Day Moving Average 14.72
10-Day Moving Average 13.69
Average True Range 1.19
RSI 46.81
ADX 19.6
+DI 18.56
-DI 18.94
Chandelier Exit (Long, 3 ATRs) 14.44
Chandelier Exit (Short, 3 ATRs) 15.38
Upper Bollinger Bands 17.20
Lower Bollinger Band 12.24
Percent B (%b) 0.41
BandWidth 33.72
MACD Line -0.43
MACD Signal Line -0.40
MACD Histogram -0.0252
Fundamentals Value
Market Cap 95.39 Million
Num Shares 669 Million
EPS
Price-to-Sales 12.40
Price-to-Book 9.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.75
Resistance 3 (R3) 15.83 15.42 15.50
Resistance 2 (R2) 15.42 15.03 15.38 15.42
Resistance 1 (R1) 14.83 14.80 14.63 14.75 15.33
Pivot Point 14.42 14.42 14.31 14.38 14.42
Support 1 (S1) 13.83 14.03 13.63 13.75 13.17
Support 2 (S2) 13.42 13.80 13.38 13.08
Support 3 (S3) 12.83 13.42 13.00
Support 4 (S4) 12.75